Chemotherapy of pulmonary tuberculosis with pneumoconiosis. Second report to the Medical Research Council from the Joint Investigators.
D000328:Adult; D000368:Aged; D000636:Aminosalicylic Acids / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000009:adverse effects; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D003875:Drug Eruptions / Q000209:etiology; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011009:Pneumoconiosis / Q000150:complications / Q000188:drug therapy*; D011658:Pulmonary Fibrosis / Q000150:complications / Q000188:drug therapy*; D013307:Streptomycin / Q000627:therapeutic use*; D014012:Tinnitus / Q000139:chemically induced; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000188:drug therapy*; D014717:Vertigo / Q000139:chemically induced
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D007538:Isoniazid; D013307:Streptomycin